Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JS']JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

被引：131

作者：

Muro, K. ^{[1
]}

Lordick, F. ^{[2
,3
]}

Tsushima, T. ^{[4
]}

Pentheroudakis, G. ^{[5
]}

Baba, E. ^{[6
]}

Lu, Z. ^{[7
]}

Cho, B. C. ^{[8
]}

Nor, I. M. ^{[9
]}

Ng, M. ^{[10
]}

Chen, L. -T. ^{[11
]}

Kato, K. ^{[12
]}

Li, J. ^{[13
]}

Ryu, M. -H. ^{[14
]}

Zamaniah, W. I. Wan ^{[15
]}

Yong, W. -P. ^{[16
]}

Yeh, K. -H. ^{[17
,18
]}

Nakajima, T. E. ^{[19
]}

Shitara, K. ^{[20
]}

Kawakami, H. ^{[21
]}

Narita, Y. ^{[1
]}

Yoshino, T. ^{[20
]}

Van Cutsem, E. ^{[22
]}

Martinelli, E. ^{[23
]}

Smyth, E. C. ^{[24
]}

Arnold, D. ^{[25
]}

Minami, H. ^{[26
]}

Tabernero, J. ^{[27
]}

Douillard, J. -Y. ^{[28
]}

机构：

[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[2] Univ Canc Ctr Leipzig, Leipzig, Germany

[3] Univ Hosp Leipzig, Dept Med Hematol & Med Oncol 1, Leipzig, Germany

[4] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan

[5] Univ Ioannina, Dept Med Oncol, Ioannina, Greece

[6] Kyushu Univ, Dept Comprehens Clin Oncol, Fukuoka, Fukuoka, Japan

[7] Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing, Peoples R China

[8] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea

[9] Gen Hosp, Dept Radiotherapy & Oncol, Kuala Lumpur, Malaysia

[10] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore

[11] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan

[12] Natl Canc Ctr, Div Gastrointestinal Med Oncol, Tokyo, Japan

[13] Tongji Univ, Affiliated East Hosp, Dept Oncol, Shanghai, Peoples R China

[14] Univ Ulsan, Coll Med, Med Ctr, Dept Oncol, Seoul, South Korea

[15] Univ Malaya, Dept Clin Oncol, Fac Med, Kuala Lumpur, Malaysia

[16] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore

[17] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan

[18] Natl Taiwan Univ, Coll Med, Ctr Canc, Taipei, Taiwan

[19] St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan

[20] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan

[21] Kindai Univ, Fac Med, Dept Med Oncol, Osaka, Japan

[22] Univ Hosp Leuven, Digest Oncol, Leuven, Belgium

[23] Univ Campania L Vanvitelli, Dept Expt Med Med Oncol, Naples, Italy

[24] Univ Cambridge, Dept Oncol, Cambridge, England

[25] Asklepios Klin Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany

[26] Kobe Univ Hosp, Dept Med Oncol & Hematol, Kobe, Hyogo, Japan

[27] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Med Oncol Dept, Barcelona, Spain

[28] ESMO, Lugano, Switzerland

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷 / 01期

关键词：

metastatic oesophageal cancer; Pan-Asian; consensus; guidelines; SQUAMOUS-CELL CARCINOMA; HER2-POSITIVE GASTRIC-CANCER; LYMPH-NODE METASTASIS; METAL STENT PLACEMENT; S-1 PLUS CISPLATIN; PHASE-II; GASTROESOPHAGEAL JUNCTION; ENTERAL NUTRITION; INTRALUMINAL BRACHYTHERAPY; NEOADJUVANT CHEMOTHERAPY;

D O I：

10.1093/annonc/mdy498

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of oesophageal cancer was published in 2016, and covered the management and treatment of local/locoregional disease, limited disease, locally advanced disease and the management of advanced/metastatic disease. At the ESMO Asia Meeting in November 2017 it was decided by both ESMO and the Japanese Society of Medical Oncology (JSMO) to convene a special guidelines meeting immediately after the JSMO Annual Meeting in 2018. The aim was to adapt the ESMO 2016 guidelines to take into account the ethnic differences associated with the treatment of metastatic oesophageal cancer in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with metastatic oesophageal cancer representing the oncological societies of Japan (JSMO), China (CSCO), Korea (KSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence, and was independent of both the current treatment practices and the drug availability and reimbursement situations in the individual participating Asian countries.

引用

页码：34 / 43

页数：10

共 69 条

[1]

Bang YJ, 2010, LANCET, V376, P1302

[2] Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015 [J].

Castro, C. ;

Bosetti, C. ;

Malvezzi, M. ;

Bertuccio, P. ;

Levi, F. ;

Negri, E. ;

La Vecchia, C. ;

Lunet, N. .

ANNALS OF ONCOLOGY, 2014, 25 (01) :283-290

[3] The pattern of cervical lymph node metastasis in thoracic esophageal squamous cell carcinoma may affect the target decision for definitive radiotherapy [J].

Chen, Junqiang ;

Cai, WenJie ;

Zheng, Xiongwei ;

Chen, Yuanmei ;

Lin, Yu ;

Chen, Xiaohui ;

Zhu, Kunshou ;

Chen, Chuanben .

RADIOTHERAPY AND ONCOLOGY, 2017, 123 (03) :382-386

[4] The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma [J].

Chen, Junqiang ;

Liu, Suoyan ;

Pan, Jianji ;

Zheng, Xiongwei ;

Zhu, Kunshou ;

Zhu, Ji ;

Xiao, Jinrong ;

Ying, Mingang .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 36 (03) :480-486

[5] Effectiveness evaluation of organized screening for esophageal cancer: a case-control study in Linzhou city, China [J].

Chen, Qiong ;

Yu, Liang ;

Hao, Changqing ;

Wang, Jinwu ;

Liu, Shuzheng ;

Zhang, Meng ;

Zhang, Shaokai ;

Guo, Lanwei ;

Quan, Peiliang ;

Germain, Patrick ;

Zhang, Yawei ;

Sun, Xibin .

SCIENTIFIC REPORTS, 2016, 6

[6]

Chen WW, 2013, ANTICANCER RES, V33, P4123

[7] ESMO-Magnitude of Clinical Benefit Scale version 1.1 [J].

Cherny, N. I. ;

Dafni, U. ;

Bogaerts, J. ;

Latino, N. J. ;

Pentheroudakis, G. ;

Douillard, J. -Y. ;

Tabernero, J. ;

Zielinski, C. ;

Piccart, M. J. ;

de Vries, E. G. E. .

ANNALS OF ONCOLOGY, 2017, 28 (10) :2340-2366

[8] The Role of Endoscopic Ultrasonography in T Staging: Early Gastric Cancer and Esophageal Cancer [J].

Cho, Jin Woong .

CLINICAL ENDOSCOPY, 2013, 46 (03) :239-242

[9] Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer [J].

Choi, Jeongmin ;

Kim, Sang Gyun ;

Kim, Joo Sung ;

Jung, Hyun Chae ;

Song, In Sung .

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2010, 24 (06) :1380-1386

[10] Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules [J].

Dafni, Urania ;

Karlis, Dimitris ;

Pedeli, Xanthi ;

Bogaerts, Jan ;

Pentheroudakis, George ;

Tabernero, Josep ;

Zielinski, Christoph C. ;

Piccart, Martine J. ;

de Vries, Elisabeth G. E. ;

Latino, Nicola Jane ;

Douillard, Jean-Yves ;

Cherny, Nathan I. .

ESMO OPEN, 2017, 2 (04)

← 1 2 3 4 5 6 7 →